201 related articles for article (PubMed ID: 35017320)
1. Decreased TMPRSS2 expression by SARS-CoV-2 predicts the poor prognosis of lung cancer patients through metabolic pathways and immune infiltration.
Liu X; Liu B; Shang Y; Cao P; Hou J; Chen F; Zhang B; Fan Y; Tan K
Aging (Albany NY); 2022 Jan; 14(1):73-108. PubMed ID: 35017320
[TBL] [Abstract][Full Text] [Related]
2.
Hu S; Hu Z; Qin J; Lin C; Jiang X
Aging (Albany NY); 2021 Jun; 13(12):15770-15784. PubMed ID: 34168096
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation.
Tang Q; Wang Y; Ou L; Li J; Zheng K; Zhan H; Gu J; Zhou G; Xie S; Zhang J; Huang W; Wang S; Wang X
Int J Biol Sci; 2021; 17(8):1925-1939. PubMed ID: 34131396
[No Abstract] [Full Text] [Related]
4. TMPRSS2 Correlated With Immune Infiltration Serves as a Prognostic Biomarker in Prostatic Adenocarcinoma: Implication for the COVID-2019.
Luo L; Zheng Y; Li M; Lin X; Li X; Li X; Cui L; Luo H
Front Genet; 2020; 11():575770. PubMed ID: 33193689
[TBL] [Abstract][Full Text] [Related]
5. Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in lung cancer.
Ilikci Sagkan R; Akin-Bali DF
J Med Virol; 2020 Nov; 92(11):2637-2647. PubMed ID: 32492203
[TBL] [Abstract][Full Text] [Related]
6. Multi-omics of the expression and clinical outcomes of TMPRSS2 in human various cancers: A potential therapeutic target for COVID-19.
Liu L; Qin JF; Zuo MZ; Zhou Q
J Cell Mol Med; 2022 Feb; 26(3):709-724. PubMed ID: 34951103
[TBL] [Abstract][Full Text] [Related]
7. Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2.
Cheng J; Zhou J; Fu S; Fu J; Zhou B; Chen H; Fu J; Wei C
J Cell Mol Med; 2021 Apr; 25(8):4157-4165. PubMed ID: 33609069
[TBL] [Abstract][Full Text] [Related]
8. Computational analysis of TMPRSS2 expression in normal and SARS-CoV-2-infected human tissues.
Cao W; Feng Q; Wang X
Chem Biol Interact; 2021 Sep; 346():109583. PubMed ID: 34284028
[TBL] [Abstract][Full Text] [Related]
9. Impact of
Fu J; Liu S; Tan Q; Liu Z; Qian J; Li T; Du J; Song B; Li D; Zhang L; He J; Guo K; Zhou B; Chen H; Fu S; Liu X; Cheng J; He T; Fu J
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364238
[TBL] [Abstract][Full Text] [Related]
10. Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide.
Li F; Han M; Dai P; Xu W; He J; Tao X; Wu Y; Tong X; Xia X; Guo W; Zhou Y; Li Y; Zhu Y; Zhang X; Liu Z; Aji R; Cai X; Li Y; Qu D; Chen Y; Jiang S; Wang Q; Ji H; Xie Y; Sun Y; Lu L; Gao D
Nat Commun; 2021 Feb; 12(1):866. PubMed ID: 33558541
[TBL] [Abstract][Full Text] [Related]
11. Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues.
Subbarayan K; Ulagappan K; Wickenhauser C; Seliger B
Curr Cancer Drug Targets; 2021 Jul; 21(5):428-442. PubMed ID: 33292131
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
[TBL] [Abstract][Full Text] [Related]
13. TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells.
Koch J; Uckeley ZM; Doldan P; Stanifer M; Boulant S; Lozach PY
EMBO J; 2021 Aug; 40(16):e107821. PubMed ID: 34159616
[TBL] [Abstract][Full Text] [Related]
14. Targeting TMPRSS2 in SARS-CoV-2 Infection.
Baughn LB; Sharma N; Elhaik E; Sekulic A; Bryce AH; Fonseca R
Mayo Clin Proc; 2020 Sep; 95(9):1989-1999. PubMed ID: 32861340
[TBL] [Abstract][Full Text] [Related]
15. Genetic Susceptibility of ACE2 and TMPRSS2 in Six Common Cancers and Possible Impacts on COVID-19.
Hoang T; Nguyen TQ; Tran TTA
Cancer Res Treat; 2021 Jul; 53(3):650-656. PubMed ID: 33421977
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW
Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814
[TBL] [Abstract][Full Text] [Related]
17. Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients.
Wulandari L; Hamidah B; Pakpahan C; Damayanti NS; Kurniati ND; Adiatmaja CO; Wigianita MR; Soedarsono ; Husada D; Tinduh D; Prakoeswa CRS; Endaryanto A; Puspaningsih NNT; Mori Y; Lusida MI; Shimizu K; Oceandy D
Hum Genomics; 2021 May; 15(1):29. PubMed ID: 34001248
[TBL] [Abstract][Full Text] [Related]
18. Transmembrane serine protease 2, a SARS-CoV-2 internalization protease, correlates with clinical outcome, molecular features, and immunotherapy response in colorectal cancer.
Zhu C; Wu J; Shelat VG; Sayagués JM; Yamamoto S; Yang L; He X
J Gastrointest Oncol; 2023 Oct; 14(5):2146-2157. PubMed ID: 37969833
[TBL] [Abstract][Full Text] [Related]
19. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
[TBL] [Abstract][Full Text] [Related]
20. TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients.
Sacconi A; Donzelli S; Pulito C; Ferrero S; Spinella F; Morrone A; Rigoni M; Pimpinelli F; Ensoli F; Sanguineti G; Pellini R; Agrawal N; Izumchenko E; Ciliberto G; Giannì A; Muti P; Strano S; Blandino G
J Exp Clin Cancer Res; 2020 Sep; 39(1):200. PubMed ID: 32967703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
